Skip to main content
Premium Trial:

Request an Annual Quote

Circulomics Wins $1.5M NIH Grant to Develop DNA/RNA Sizing Platform

NEW YORK (GenomeWeb) – Circulomics announced today that it has been awarded a $1.5 million Phase II SBIR grant from the National Institutes of Health to develop a single-molecule platform for DNA and RNA sample quality analysis.

According to the company, the platform will be based on its PicoSep instrument, which uses inline isotachophoresis preconcentration and single-molecule free solution hydrodynamic separation to enable DNA and RNA sizing from picoliters of a sample and 20 DNA molecules.

With funding from the two-year grant, Circulomics aims to develop a high-throughput PicoSep-based kits for sample preparation for two applications: high molecular weight DNA sizing and RNA integrity analysis.

The company said it plans to develop future kits for determining advanced DNA/RNA metrics such as damage from abasic sites and oxidation.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.